The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The peptide problem: Hype is outrunning the evidence Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law BPC 157 benefits, dosage, and side effects BPC 157 LeadWest Medical FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling